MA39074B1 - Combination therapy with an anti-ang 2 antibody and a cd40 agonist - Google Patents

Combination therapy with an anti-ang 2 antibody and a cd40 agonist

Info

Publication number
MA39074B1
MA39074B1 MA39074A MA39074A MA39074B1 MA 39074 B1 MA39074 B1 MA 39074B1 MA 39074 A MA39074 A MA 39074A MA 39074 A MA39074 A MA 39074A MA 39074 B1 MA39074 B1 MA 39074B1
Authority
MA
Morocco
Prior art keywords
ang
agonist
antibody
combination therapy
binds
Prior art date
Application number
MA39074A
Other languages
French (fr)
Other versions
MA39074A1 (en
Inventor
Christian Klein
Philipp Mueller
Markus Thomas
Alfred Zippelius
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority claimed from PCT/EP2014/078233 external-priority patent/WO2015091655A1/en
Publication of MA39074A1 publication Critical patent/MA39074A1/en
Publication of MA39074B1 publication Critical patent/MA39074B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies

Abstract

La présente invention concerne la polythérapie avec un anticorps qui se lie à l'angiopoïétine 2 humaine (ang -2) avec un agoniste cd40.The present invention relates to combination therapy with an antibody that binds to human angiopoietin 2 (ang -2) with a cd40 agonist.

MA39074A 2013-12-20 2014-12-17 Combination therapy with an anti-ang 2 antibody and a cd40 agonist MA39074B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13198753 2013-12-20
PCT/EP2014/078233 WO2015091655A1 (en) 2013-12-20 2014-12-17 Combination therapy with an anti-ang2 antibody and a cd40 agonist

Publications (2)

Publication Number Publication Date
MA39074A1 MA39074A1 (en) 2018-07-31
MA39074B1 true MA39074B1 (en) 2019-10-31

Family

ID=49876441

Family Applications (1)

Application Number Title Priority Date Filing Date
MA39074A MA39074B1 (en) 2013-12-20 2014-12-17 Combination therapy with an anti-ang 2 antibody and a cd40 agonist

Country Status (2)

Country Link
AR (1) AR098790A1 (en)
MA (1) MA39074B1 (en)

Also Published As

Publication number Publication date
AR098790A1 (en) 2016-06-15
MA39074A1 (en) 2018-07-31

Similar Documents

Publication Publication Date Title
PH12016500482A1 (en) Combination therapy with an anti-ang2 antibody and a cd40 agonist
MY191169A (en) Anti-fcrh5 antibodies
MA43187A (en) SUBCUTANEOUS ANTI-CD38 ANTIBODY FORMULATIONS AND THEIR USES
MA39095A1 (en) Anti-cd33 antibodies and immunoconjugates
MA40576B1 (en) Anti-her2 antibodies and immunoconjugates
MA47694A (en) ANTI-TIGIT ANTIBODY
MA49034A (en) ANTI-LAG3 ANTIBODY
MA38273A1 (en) Combination therapy with anti-her3 antibodies
MA53434A (en) ANTI-TIGIT ANTIBODIES
MA52884A (en) ANTI-IL-11 ANTIBODIES
MA40938A (en) ANTI-CD79B ANTIBODIES AND METHODS OF USE OF SUCH ANTIBODIES
MA40682A (en) ANTI-OX40 ANTIBODIES AND CORRESPONDING METHODS OF USE
MA47268A (en) ANTIBODY ANTI-GPC3
MA39248B1 (en) Anti-jagged1 antibodies and methods of use thereof
EA201591750A1 (en) ANTIBODIES AGAINST B7-H4 AND IMMUNOCONJUGATES
MA37538B1 (en) Anti-Ly6 antibodies and immunoconjugates and methods of use
MA52366A (en) OPTIMIZED ANTI-TL1A ANTIBODIES
FR3021970B1 (en) ANTIBODY AGAINST GALECTIN 9 AND INHIBITOR OF THE SUPPRESSIVE ACTIVITY OF T REGULATORY LYMPHOCYTES
MA38797A1 (en) Therapeutic fusion protein
MX2016004853A (en) ANTI-Ly6E ANTIBODIES AND METHODS OF USE.
MA52152A (en) ANTIBODY
PH12015501854A1 (en) Factor ix polypeptide formulations
MA51135A (en) ANTI-ALPHA-SYNUCLEIN ANTIBODY
MA50654A (en) ANTI-PACAP ANTIBODIES
MA56466A (en) ANTI-EPHA4 ANTIBODIES